Cargando…

Association of In‐Hospital Hemoglobin Drop With Decreased Myocardial Salvage and Increased Long‐Term Mortality in Patients With Acute ST‐Segment–Elevation Myocardial Infarction

BACKGROUND: Anemia and blood loss occur often in patients with ST‐segment–elevation myocardial infarction (STEMI). In‐hospital hemoglobin drop is associated with 1‐year mortality in patients with acute coronary syndrome. However, data on the effect of hemoglobin reduction on myocardial salvage and l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dutsch, Alexander, Graesser, Christian, Voll, Felix, Novacek, Sophie, Eggerstedt, Robert, Armbruster, Nicolás López, Laugwitz, Karl‐Ludwig, Cassese, Salvatore, Schunkert, Heribert, Ndrepepa, Gjin, Kastrati, Adnan, Kessler, Thorsten, Sager, Hendrik B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496425/ https://www.ncbi.nlm.nih.gov/pubmed/36000430 http://dx.doi.org/10.1161/JAHA.121.024857

Ejemplares similares

Time-of-day at symptom onset was not associated with infarct size and long-term prognosis in patients with ST-segment elevation myocardial infarction
por: Sager, Hendrik B., et al.
Publicado: (2019)

Prior Myocardial Infarction and Treatment Effect of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndromes ‐ A Post‐hoc Analysis of the ISAR‐REACT 5 Trial
por: Lahu, Shqipdona, et al.
Publicado: (2022)

Association of De Ritis Ratio with Prognosis in Patients with Coronary Artery Disease and Aminotransferase Activity within and outside the Healthy Values of Reference Range
por: Ndrepepa, Gjin, et al.
Publicado: (2023)

Periprocedural myocardial injury according to optical characteristics of neointima and treatment modality of in-stent restenosis
por: Nano, Nejva, et al.
Publicado: (2022)

Early Aspirin Discontinuation After Coronary Stenting: A Systematic Review and Meta‐Analysis
por: Wiebe, Jens, et al.
Publicado: (2021)

Coronary No-Reflow after Primary Percutaneous Coronary Intervention—Current Knowledge on Pathophysiology, Diagnosis, Clinical Impact and Therapy
por: Ndrepepa, Gjin, et al.
Publicado: (2023)

Effect of Erythropoietin in patients with acute myocardial infarction: five-year results of the REVIVAL-3 trial
por: Steppich, Birgit, et al.
Publicado: (2017)

Assessment of Impact of Patient Recruitment Volume on Risk Profile, Outcomes, and Treatment Effect in a Randomized Trial of Ticagrelor Versus Prasugrel in Acute Coronary Syndromes
por: Ndrepepa, Gjin, et al.
Publicado: (2021)

Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes
por: Koch, Tobias, et al.
Publicado: (2023)

Quo Vadis? Immunodynamics of Myeloid Cells after Myocardial Infarction
por: Moggio, Aldo, et al.
Publicado: (2022)

Influence of body size on platelet response to ticagrelor and prasugrel in patients with acute coronary syndromes
por: Ndrepepa, Gjin, et al.
Publicado: (2021)

High on-aspirin treatment platelet reactivity and restenosis after percutaneous coronary intervention: results of the Intracoronary Stenting and Antithrombotic Regimen-ASpirin and Platelet Inhibition (ISAR-ASPI) Registry
por: Mayer, Katharina, et al.
Publicado: (2023)

Antithrombotic therapy with or without clopidogrel after transcatheter aortic valve replacement. A meta-analysis of randomized controlled trials
por: Pellegrini, Costanza, et al.
Publicado: (2020)

Efficacy and Safety of Ticagrelor Versus Prasugrel in Women and Men with Acute Coronary Syndrome: A Pre-specified, Sex-Specific Analysis of the ISAR-REACT 5 Trial
por: Gewalt, Senta, et al.
Publicado: (2022)

SARS-CoV-2 Infection in Asymptomatic Patients Hospitalized for Cardiac Emergencies: Implications for Patient Management
por: Kessler, Thorsten, et al.
Publicado: (2020)

Comparative prognostic value of C-reactive protein & fibrinogen in patients with coronary artery disease
por: Ndrepepa, Gjin, et al.
Publicado: (2014)

Machine Learning Identifies New Predictors on Restenosis Risk after Coronary Artery Stenting in 10,004 Patients with Surveillance Angiography
por: Güldener, Ulrich, et al.
Publicado: (2023)

ISAR‐PEBIS (Paclitaxel‐Eluting Balloon Versus Conventional Balloon Angioplasty for In‐Stent Restenosis of Superficial Femoral Artery): A Randomized Trial
por: Ott, Ilka, et al.
Publicado: (2017)

Long‐Term Ticagrelor Versus Prasugrel Pharmacodynamics in Patients With ST‐Segment–Elevation Myocardial Infarction
por: Cassese, Salvatore, et al.
Publicado: (2020)

Ten-year clinical outcomes of polymer-free versus durable polymer new-generation drug-eluting stent in patients with coronary artery disease with and without diabetes mellitus: Results of the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol- and Zotarolimus-Eluting Stents (ISAR-TEST 5) trial
por: Koch, Tobias, et al.
Publicado: (2021)

Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trial
por: Behnes, Michael, et al.
Publicado: (2022)

Tolvaptan in the very elderly with acute decompensated heart failure-a therapeutic option worth of consideration
por: Ndrepepa, Gjin
Publicado: (2017)

Atherosclerosis & ischaemic heart disease: Here to stay or gone tomorrow
por: Ndrepepa, Gjin
Publicado: (2017)

Epicardial adipose tissue: An anatomic component of obesity & metabolic syndrome in close proximity to myocardium & coronary arteries
por: Ndrepepa, Gjin
Publicado: (2020)

RAAS inhibition and beyond—cardiovascular medications in patients at risk of or affected by COVID-19
por: Dutsch, Alexander, et al.
Publicado: (2023)

Ten‐Year Clinical Outcomes of Biodegradable Versus Durable Polymer New‐Generation Drug‐Eluting Stent in Patients With Coronary Artery Disease With and Without Diabetes Mellitus
por: Lenz, Tobias, et al.
Publicado: (2021)

Kardiovaskuläre Manifestationen von COVID-19
por: Dutsch, Alexander, et al.
Publicado: (2021)

Multi-Omic Candidate Screening for Markers of Severe Clinical Courses of COVID-19
por: Dutsch, Alexander, et al.
Publicado: (2023)

Predicting factors for long-term survival in patients with out-of-hospital cardiac arrest – A propensity score-matched analysis
por: Lahmann, Anna Lena, et al.
Publicado: (2020)

Target and non-target vessel related events at 10 years post percutaneous coronary intervention
por: Coughlan, J. J., et al.
Publicado: (2022)

Impact of Acute and Chronic Psychosocial Stress on Vascular Inflammation
por: Hinterdobler, Julia, et al.
Publicado: (2021)

Functional evaluation of GUCY1A3 mutations associated with myocardial infarction risk
por: Wobst, Jana, et al.
Publicado: (2015)

Where the Action Is—Leukocyte Recruitment in Atherosclerosis
por: Mauersberger, Carina, et al.
Publicado: (2022)

Myocardial salvage after myocardial infarction depends on early therapy
Publicado: (2010)

A proteomic atlas of the neointima identifies novel druggable targets for preventive therapy
por: Wierer, Michael, et al.
Publicado: (2021)

Investigating the impact of a mutation in PDE5A on myocardial infarction
por: Dang, Tan A, et al.
Publicado: (2015)

Colchicine Impacts Leukocyte Trafficking in Atherosclerosis and Reduces Vascular Inflammation
por: Meyer-Lindemann, Ulrike, et al.
Publicado: (2022)

Morphine Does Not Affect Myocardial Salvage in ST-Segment Elevation Myocardial Infarction
por: Gwag, Hye Bin, et al.
Publicado: (2017)

Inflammation-Related Risk Loci in Genome-Wide Association Studies of Coronary Artery Disease
por: Mauersberger, Carina, et al.
Publicado: (2021)

Peri-infarct edema leads to overestimation of myocardial salvage in late reperfused myocardial infarction
por: Carbone, Iacopo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_tq3kjv06padutvjq3cuj4ktoat